Ontology highlight
ABSTRACT:
SUBMITTER: Villanueva N
PROVIDER: S-EPMC6144513 | biostudies-literature | 2018 Jan-Dec
REPOSITORIES: biostudies-literature
Villanueva Nicolas N Bazhenova Lyudmila L
Therapeutic advances in respiratory disease 20180101
Immunotherapy has significantly altered the treatment landscape for many cancers, including non-small cell lung cancer (NSCLC). Currently approved immuno-oncology agents for lung cancer are aimed at the reversal of immune checkpoints, programmed death protein-1 (PD-1) and programmed death ligand-1 (PD-L1). Although responses to checkpoint inhibitors are encouraging, and in some cases durable, these successes are not universal among all treated patients. In order to optimize our treatment approac ...[more]